Sheel Biotech bulk deals and insider trading
NSE: SHEELCommercial Services & Supplies
Share price at the NSE close on 23 Oct 2026. Previous close ₹60.05.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹120 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 May 2026
- 10.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 28 May 2026
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,000100.0% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Sheel Biotech promoter holding
- Promoters and promoter group1 purchase, 0 sales₹0.04 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.04 Cr
Sheel Biotech insider trading
All 7 disclosures on record.Insider trading, all companies
Feb 2026
- Mr. Sanjay Chandak₹0.10 Cr16,000 sharesBought · Promoter And Designated Person · 23 Feb 2026 · disclosed 7 Apr
- Mr. Satya Narayan Chandak₹0.10 Cr16,000 sharesBought · Promoter And Designated Person · 23 Feb 2026 · disclosed 7 Apr
- Mr. Sanjay Chandak₹0.09 Cr14,000 sharesBought · Promoter And Designated Person · 6 Feb 2026 · disclosed 7 Apr
- Mr. Sanjay Chandak₹0.08 Cr12,000 sharesBought · Promoter And Designated Person · 3 Feb 2026 · disclosed 7 Apr
Jan 2026
- Mr. Divye Chandak₹0.12 Cr18,000 sharesBought · Promoter And Designated Person · 23 Jan 2026 · disclosed 7 Apr
- Mr. Sanjay Chandak₹0.13 Cr18,000 sharesBought · Promoter And Designated Person · 20 Jan 2026 · disclosed 7 Apr
- Satya Narayan Chandak₹0.04 Cr6,000 sharesBought · Promoters · 8 Jan 2026 · stake 7.42% before, 7.45% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Sheel Biotech bulk deals
Last 12 months, since 23 Oct 2025: 3 bulk deals, ₹1.74 Cr bought and ₹0.74 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 18 Jun 20261 firm · ₹1.09 Cr bought · ₹0 soldNet bought ₹1.09 Cr
- BoughtBAKUL CHATURBHAI LIMBASIYABought 1,50,000 at ₹72.900.74% of the company₹1.09 Cr
Monday 16 Feb 20262 firms · ₹0.65 Cr bought · ₹0.74 Cr soldNet sold ₹0.09 Cr
- SoldSHUBHAM SANJAY DAMANISold 1,16,000 at ₹63.570.57% of the company₹0.74 Cr
- BoughtLONGVIEW RESEARCH AND ADVISORY SERVICES PRIVATE LIMITEDBought 1,02,000 at ₹63.330.50% of the company₹0.65 Cr
Monday 13 Oct 20251 firm · ₹1.07 Cr bought · ₹0.49 Cr soldNet bought ₹0.57 Cr
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 1,30,000 at ₹82.00Sold 60,000 at ₹82.00Net +70,000 shares₹1.07 Cr bought
Wednesday 8 Oct 20256 firms · ₹3.94 Cr bought · ₹3.33 Cr soldNet bought ₹0.61 Cr
- SoldCRAFT EMERGING MARKET FUND PCC- CITADEL CAPITAL FUNDSold 1,36,000 at ₹91.00₹1.24 Cr
- BoughtPREETI BHAUKABought 1,34,000 at ₹91.00₹1.22 Cr
- BoughtSHUBHAM SANJAY DAMANIBought 1,24,000 at ₹91.00₹1.13 Cr
- BoughtSMP SECURITIES LTDBought 1,12,000 at ₹91.00₹1.02 Cr
- SoldLONGTHRIVE CAPITAL VCC - GAMMA VIEW FUNDSSold 1,06,000 at ₹91.23₹0.97 Cr
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 60,000 at ₹95.55Sold 1,22,000 at ₹92.06Net −62,000 shares₹0.57 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 12 deals on record since listing on 8 Oct 2025.